Covance Not Cooling...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$37.25 0.70 | 1.92%
05/17/13 - 04:00 PM ET
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest GHDX Headlines from TheStreet
- Top Insider Trades: DXM, SPB, AMTD, GHDX 05.17.13 | 08:05 am
- 5 Stocks Insiders Love Right Now 05.15.13 | 12:05 pm
- Top Insider Trades: GHDX WES GGP X 05.15.13 | 09:05 am
- Tech That Disrupts Our Lives for the Better 05.10.13 | 02:05 pm
- GHDX Crosses Above Key Moving Average Level 05.02.13 | 04:05 pm
- 4 Stocks Rising on Unusual Volume 03.29.13 | 07:03 am
- Top Insider Trades: GHDX, CLMS, IRM, FAST 02.22.13 | 09:02 am
- 5 Stocks With Big Insider Buying 02.13.13 | 12:02 pm
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
Press Releases for GHDX
- Genomic Health Announces Publication Of Second Positive Validation Of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers - PR Newswire 04.17.13 | 08:04 am
- Genomic Health To Address One Of The Most Significant Needs In Men's Health With The Oncotype DX® Prostate Cancer Test - PR Newswire 04.03.13 | 08:04 am
- Genomic Health Presents Twenty Two International Studies Demonstrating Worldwide Adoption And Value Of Oncotype DX® Breast Cancer Test - PR Newswire 03.15.13 | 08:03 am
- Genomic Health Announces Positive Results From Large Study Of Oncotype DX® To Quantify Risk Of Loco-Regional Recurrence In Node-positive Breast Cancer Patients And Acceptance Of Oncotype DX DCIS Validation Study For Publication - PR Newswire 03.13.13 | 08:03 am
- Genomic Health Announces Results From Two Studies Demonstrating Innovations In Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding Of Tumor Biology - PR Newswire 02.25.13 | 08:02 am
- Genomic Health To Announce Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On Wednesday, February 6, 2013 - PR Newswire 01.30.13 | 08:01 am
- Genomic Health Announces New Evidence Further Demonstrating Clinical Utility And Cost-Effectiveness Of Oncotype DX In Colon Cancer - PR Newswire 01.23.13 | 08:01 am
- Genomic Health To Present At The J.P. Morgan Healthcare Conference - PR Newswire 12.21.12 | 08:12 am
- Genomic Health Announces Presentation Of Six Studies At The 2012 CTRC-AACR San Antonio Breast Cancer Symposium - PR Newswire 11.28.12 | 08:11 am
- Genomic Health To Present At Two Upcoming Investor Conferences - PR Newswire 11.09.12 | 08:11 am
Partner Headlines for GHDX
- Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.12.12 | 03:09 pm
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Agilent Wins Patent in US - Analyst Blog - NASDAQ 08.21.12 | 07:08 pm
- Genomic Health Back to Neutral - Analyst Blog - NASDAQ 08.20.12 | 11:08 pm
- Genomic Health Beats on EPS - Analyst Blog - Zacks 08.09.12 | 10:08 am
- CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares - GuruFocus 07.13.12 | 02:07 pm
- Medical Sector Shows Muscle With SXC Health, Cerner - Investor's Business Daily 06.21.12 | 06:06 pm
- 4 Stocks With Heavy Insider Buying - Seeking Alpha 02.24.12 | 08:02 am
- Myriad Beats, Raises Guidance - Analyst Blog - Zacks 02.01.12 | 09:02 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
